# Multimodalitic Imaging in the N-stage of Lung Cancer

> **NCT05840094** · NA · UNKNOWN · sponsor: **Peking University First Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Neoplasm of Lung

## Interventions

- **DRUG:** 18F-FDG
- **DEVICE:** MR STIR
- **PROCEDURE:** EBUS-TBNA

## Key facts

- **NCT ID:** NCT05840094
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-05-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05840094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05840094, "Multimodalitic Imaging in the N-stage of Lung Cancer". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05840094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*